| Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition S Kulsum, HV Sudheendra, R Pandian, DR Ravindra, G Siddappa, ... Molecular carcinogenesis 56 (2), 694-711, 2017 | 75 | 2017 |
| Discovery and development of SPR519 as a potent, selective, and orally bioavailable inhibitor of PI3Kα and mTOR kinases for the treatment of solid tumors D Mahajan, S Sen, B Kuila, A Sharma, R Arora, M Sagar, AR Mahapatra, ... Journal of Medicinal Chemistry 63 (19), 11121-11130, 2020 | 9 | 2020 |
| BCA101 is a tumor-targeted bifunctional fusion antibody that simultaneously inhibits EGFR and TGFβ signaling to durably suppress tumor growth SR Boreddy, R Nair, PK Pandey, A Kuriakose, SB Marigowda, C Dey, ... Cancer Research 83 (11), 1883-1904, 2023 | 5 | 2023 |
| SPR965: an oral PI3K/mTOR C1/C2 inhibitor for the treatment of solid tumors R Arora, BK Dutta, R Goel, FP Hollinger, B Kulia, D Mahajan, ... Cancer Research 74 (19_Supplement), 4515-4515, 2014 | 3 | 2014 |
| Significance of animal experimentation in biomedical research in the current era: Narrative review SS Sakat, O Bagade, G Mhaske, P Taru, M Sagar, M Rastogi Journal of Applied Pharmaceutical Science 12 (10), 011-019, 2022 | 2 | 2022 |
| Diabetes mellitus manifestations and challenges in post-COVID-19 syndrome: A critical review SS Sakat, V Kuvar, A Kharche, M Sagar, PK Pandey, O Bagade, ... Journal of Applied Pharmaceutical Science, 2024 | | 2024 |
| BCA101, a novel tumor-targeted bifunctional fusion antibody simultaneously inhibiting EGFR and TGF-β signaling with potential for durable tumor growth inhibition SR Boreddy, R Nair, PK Pandey, A Kuriakose, A Banerjee, C Dey, ... Cancer Research 83 (7_Supplement), 6339-6339, 2023 | | 2023 |
| 1368 A novel bispecific BCA356 targeting tumour antigen CAIX conjugated to an attenuated IL12 demonstrates pre-clinical efficacy with potential for limited systemic toxicity P Nair, A Goswamy, J Bhatnagar, S Boreddy, R Nair, S Krishn, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
